Pharmaceutical Business Review

DECEMBER 27, 2024

This collaboration aims to leverage Axcelead’s DegLead Platform, an integrated service solution designed for the next generation of small-molecule drug discovery, to support Astellas discovery efforts and contribute to the generation of drug candidate compounds.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Drug Patent Watch

JUNE 17, 2024

Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs.

Compounding 104

Compounding Pharmaceutical Companies Pharmaceutical Companies 104

Pharmafile

JANUARY 20, 2023

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process.

Compounding 52

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

OCTOBER 24, 2023

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 This is projected to grow at the highest compound annual growth rate of 5.27

Packaging 118

Packaging Labelling Compounding Pharmaceutical Companies 118

Drug Patent Watch

MARCH 18, 2025

billion by 2025, with a compound annual growth rate (CAGR) of 10.5%. One company that stands out is R-Pharm, a leading Russian pharmaceutical company that has been at the forefront of innovation in the country. According to a recent report, the Russian pharma market is expected to reach $24.5

Biosimilars 90

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Compounding 90

pharmaphorum

MARCH 19, 2021

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this. Follow him on Twitter or connect with him on LinkedIn.

Compounding 141

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 141

Drug Patent Watch

DECEMBER 18, 2024

Jane Smith, a patent attorney specializing in pharmaceuticals, advises: “File early and file often. From initial compound discovery to formulation improvements, every step offers opportunities for patent protection.” Common choices include the US, EU, Japan, China, and other major pharmaceutical markets.

Drug Development 95

Drug Development Compounding Dosage Pharmaceutical Companies 95

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical compounding is a method of preparing personalised medications for patients by mixing the individual ingredients in the exact strength and dosage form required by the patient. Discover the top pharmaceutical compounding companies in contract marketing. Active pharmaceutical ingredients (APIs).

Compounding 40

Compounding Compounding Pharmacies Sterile Compounds Dosage 40

European Pharmaceutical Review

OCTOBER 3, 2023

Consequently, this reduces the number of animals used for toxicity testing by and/or allowing the toxicologist to leverage historical in vivo toxicology data available in literature for the target compound or structurally similar compounds, the authors stated. Method and results Positively, Masuda-Herrera et al.

Compounding 105

Compounding Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

NOVEMBER 25, 2024

The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 An increasing trend of outsourcing boosts growth of the market as pharmaceutical companies are utilising advanced testing capabilities and optimising their drug development processes. billion by 2032. percent between 2024 and 2032.

Drug Development 52

Drug Development Biosimilars Compounding Pharmaceutical Companies 52

Express Pharma

JUNE 13, 2024

The amyotrophic lateral sclerosis (ALS) market across the 8MM (8MM: the US, France, Germany, Italy, Spain, the UK, Japan, and Canada) is projected to grow at a compound annual growth rate (CAGR) of 15 per cent from $317 million in 2019 to $1.28 billion in 2029, forecasts GlobalData.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Compounding 98

European Pharmaceutical Review

OCTOBER 31, 2022

Ensuring that small and emerging pharmaceutical companies have access to expertise and resources is especially important. 2 However, smaller companies may have limited in-house resources and lack the capabilities to solve the challenges to meet important milestones during early-stage development.

Compounding 125

Compounding Drug Development Pharmaceutical Companies Pharmaceutical Companies 125

Express Pharma

JUNE 11, 2024

With the evolving landscape of drug development and innovations, several institutes are serving as catalysts by partnering with pharmaceutical companies to drive progress at various stages of research and development. Due to the strong infrastructure and expertise offered by institutes, pharma companies collaborate with institutes.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development Compounding 105

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

AUGUST 3, 2023

.” Implementing quality standards for medicinal cannabis Mikael Sodergren of Curaleaf International explained in an article published on EPR’s website last month: “there is a vast range of flavonoids, terpenoids, phytols and other compounds present at lower concentrations within the cannabis flower”.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

FEBRUARY 3, 2023

The facility forms two new fully-automated production lines for liquid and freeze-dried drugs, including highly potent compounds and advanced therapies such as antibody drug conjugates (ADCs). Positively, it comes at a time when securing fill finish capacity can be a challenge for many pharmaceutical companies.

Dosage 98

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

NOVEMBER 3, 2021

The report refers to data collected across 350+ global pharma companies between November 2020 through January 2021, and notes a 70% compound average growth rate in the volume of content managed in Veeva Vault PromoMats since 2018. Veeva is the global leader in cloud software for the life sciences industry.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Pathway

SEPTEMBER 14, 2022

is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Company Name: Dr. Reddy’s Laboratories. Reddy’s Laboratories Ltd.-Walk-In

Biosimilars 77

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 77

Express Pharma

JUNE 28, 2024

The osteoporosis market, the prevailing metabolic bone disorder globally, which is characterised by reduced bone mineral density and increased fracture risk, is set to experience a compound annual growth rate (CAGR) of 5.4 per cent across the seven major markets (7MM*) from $10.5 billion in 2023 to $17.9 billion in 2033, forecasts GlobalData.

Biosimilars 105

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 105

Pharmafile

MARCH 3, 2023

US-based pharmaceutical company Eli Lilly has signed a small licensing deal with Belgian start-up Confo Therapeutics to allow them access to the rights for a group of compounds headed by CFTX-1554. CFTX-1554 is in development as a treatment for neuropathic pain which is the result of damage to the peripheral nerve cells.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

SEPTEMBER 28, 2022

Nitrosamine impurities are undesirable organic compounds with genotoxic, carcinogenic and mutagenic activity. concluded that, as a result: “The developed method can be used as a standard method to assess of presence of NDMA in olmesartan and other drug substances of sartanes for pharmaceutical companies and researchers.”.

Compounding 105

Compounding Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

AUGUST 30, 2023

Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding generic medicines, beckons for clarity.

Generic Medicine 110

Generic Medicine Dosage Compounding Pharmaceutical Companies 110

European Pharmaceutical Review

OCTOBER 7, 2022

billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 The rising requirement for small-scale and encapsulated manufacturing processes necessary to assemble these products make it challenging for many pharmaceutical companies to alter their currently installed capacity.

Dosage 98

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

MAY 31, 2023

The University of Sydney and Australian company Pharos Therapeutics have reached an agreement to leverage artificial intelligence (AI) to progress drug discoveries for the treatment of cancer and rare diseases. It is focused on the development of new compounds.

Data Entry 59

Data Entry Compounding Drug Development Pharmaceutical Companies 59

European Pharmaceutical Review

AUGUST 17, 2022

billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.2 Pharmaceutical companies globally are significantly investing in R&D. According to a recent report , the global formulation development outsourcing market size should grow to $61.4 percent from its 2022 value of $35.1

Compounding 96

Compounding Pharmaceutical Companies Pharmaceutical Companies Drug Development 96

Eye on FDA

AUGUST 2, 2022

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

Communication 88

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 88

pharmaphorum

OCTOBER 7, 2022

Expert speaking companies include Plexium , Stanford University Medical School, Seed Therapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Kymera Therapeutics, Foghorn Therapeutics & many more. View the full event guide here. The post TPD Assay Development & Screening Summit appeared first on.

Medical Schools 52

Medical Schools Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

APRIL 3, 2024

Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. As such, the sector is expected to grow at a compounded annual growth rate (CAGR) of 6.5 Increasing the outsourcing of manufacturing activities is helping pharmaceutical companies to focus on their core capabilities.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Compounding 52

European Pharmaceutical Review

FEBRUARY 21, 2023

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Advising companies, he emphasised that those “manufacturing cannabis-based medicines should not underestimate the scale of the challenge.”

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies Compounding Drug Development 132

Pharmaceutical Technology

FEBRUARY 23, 2023

Innovation S-curve for artificial Intelligence in the pharmaceutical industry In-silico drug discovery is a key innovation area in artificial Intelligence Drug research starts with the discovery stage that involves in vivo and in vitro models to shortlist lead drug compounds.

Compounding 75

Compounding Pharmaceutical Companies Pharmaceutical Companies 75

pharmaphorum

FEBRUARY 9, 2022

Closely related to this is the fact that global spending on oncology drugs reached $164 billion in 2020, with drug sales growing at a compound annual growth rate of 14.3% The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.

Vaccines 134

Vaccines Immunization Immunity Labelling 134

Pharmaceutical Business Review

AUGUST 13, 2024

Through high-throughput screening and the application of AI and machine learning, the company aims to fast-track the creation and approval of innovative drug delivery systems that can meet unmet medical needs and improve patient care. Additionally, Nivagen provides 503B compounding services to institutional clients.

Dosage 59

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

DECEMBER 21, 2022

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. However, it is already clear that the investments will be gargantuan.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

JULY 7, 2023

Despite a strong research base and an emerging data science sector targeting pharma R&D, the UK has not been successful in growing large UK biopharma companies. The sector is dominated by small and medium-sized enterprises (SMEs) that are frequently acquired by companies from the US or elsewhere before they scale-up.

Compounding 104

Compounding Pharmaceutical Companies Pharmaceutical Companies 104

Pharmaceutical Business Review

OCTOBER 9, 2024

Its drug discovery platforms such as SmartCube, NeuroCube, PhenoCube, and eCube have been instrumental in shared risk partnerships with pharmaceutical companies sush as like Sunovion and Roche.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

APRIL 8, 2024

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

Express Pharma

OCTOBER 16, 2024

The CRO sector in India, growing at a compound annual growth rate (CAGR) of 10.75 Similarly, India’s pharmaceutical contract manufacturing market is expected to increase at a CAGR of 14.67 per cent, is projected to reach $2.5 billion by 2030 (2). per cent, hitting $44.63 billion by 2029 (3).

Biosimilars 103

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 103